0000950170-23-064833.txt : 20231117 0000950170-23-064833.hdr.sgml : 20231117 20231117162211 ACCESSION NUMBER: 0000950170-23-064833 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231115 FILED AS OF DATE: 20231117 DATE AS OF CHANGE: 20231117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WIINBERG ULF CENTRAL INDEX KEY: 0001187314 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-29089 FILM NUMBER: 231419023 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AGENUS INC CENTRAL INDEX KEY: 0001098972 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 061562417 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-674-4410 MAIL ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: ANTIGENICS INC /DE/ DATE OF NAME CHANGE: 19991115 4 1 ownership.xml 4 X0508 4 2023-11-15 0001098972 AGENUS INC AGEN 0001187314 WIINBERG ULF C/O AGENUS INC. 3 FORBES ROAD LEXINGTON MA 02421 true false false false false Common Stock 2023-11-15 4 P false 25000 0.76 A 124063 D Represents open market purchase of common stock for cash. /s/Christine Klaskin, as Attorney-in-Fact for Ulf Wiinberg 2023-11-17